The relationship between antimanic agent for treatment of classic or dysphoric mania and length of hospital stay

Journal of Clinical Psychiatry

Volumn 57, Issue 1, 1996, Pages 17-21

  Frye, Mark A ^b   Altshuler, Lori L ^a   Szuba, Martin P ^b   Finch, Nancy Nowlin ^b   Mintz, Jim ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; LITHIUM; VALPROATE SEMISODIUM;

ADULT; ARTICLE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DYSPHORIA; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; MOOD; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REGRESSION ANALYSIS; TREATMENT OUTCOME;

ADULT; ANTIMANIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; CARBAMAZEPINE; DRUG THERAPY, COMBINATION; FEMALE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; LITHIUM; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VALPROIC ACID;

EID: 0030071272     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Schou M, Juel-Nielsen N, Stromgren E, et al. The treatment of manic psychosis by the administration of lithium salts. J Neurol Neurosurg Psychiatry 1954;17:250-260
2. Goodwin FK, Murphy DL, Bunney WE. Lithium carbonate treatment in depression and mania. Arch Gen Psychiatry 1969;21:485-496
3. Ballenger JC, Post RM. Therapeutic effects of carbamazepine in affective illness: a preliminary report [letter]. Communications in Psychopharmacology 1978;2:159
4. Ballenger JC, Post RM. Carbamazepine in manic depressive illness: a new treatment. Am J Psychiatry 1980;137:782-790
5. Okuma T, Inanaga K, Otsuki S, et al. Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: a double blind controlled study. Psychopharmacology (Berl) 1979;66:211
6. Pope HG Jr, McElroy SL, Keck PE Jr Valproate in acute mania: a controlled trial. Arch Gen Psychiatry 1991;48:62-68
7. Small JG, Klapper M, Milstein V, et al. Carbamazepine compared to lithium in the treatment of mania. Arch Gen Psychiatry 1991;48:915-921
8. Lerer B, Moore N, Meyendorff E, et al. Carbamazepine versus lithium in mania: a double-blind study J Clin Psychiatry 1987;48:89-93
9. Bowden CL, Depakote Mania Study Group. Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 1994;271:918-924
10. Freeman TW, Clothier JL, Pazzaglia P, et al. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 1992;149:108-111
11. Kramlinger KG, Post RM. Adding lithium carbonate to carbamazepine: antimanic efficacy in treatment resistant mania. Acta Psychiatr Scand 1989;79:378-385
12. Ketter TA, Pazzaglia PJ, Post RM. Synergy of carbamazepine and valproic acid in affective illness: case report and review of the literature. J Clin Psychopharmacol 1992;12:276-281
13. Keck PE Jr, McElroy SL, Vuckovic A, et al. Combined valproate and carbamazepine treatment of bipolar disorder. J Neuropsychiatry Clin Neurosci 1992;4:319-322
14. Gerner RH. Treatment of acute mania. Psychiatr Clin North Am 1993; 16:443-460
15. Vestergaard P. Treatment and prevention of mania: a Scandinavian perspective. Neuropsychopharmacology 1992;7:249-259
16. Keck PE Jr, McElroy SL, Nemeroff CB. Anticonvulsants in the treatment of bipolar disorder. J Neuropsychiatry Clin Neurosci 1992;4:395-405
17. Gelenberg AJ. Practitioner's Guide to Psychoactive Drugs. 3rd ed New York, NY: Plenum; 1991
18. Post RM, Uhde TW, Roy-Byrne PP, et al. Correlates of antimanic response to carbamazepine. Psychiatry Res 1987;21:71-83
19. Rail TW, Schleifer LS. Drugs effective in the therapy of the epilepsies. In: Gilman AG, Goodman LS, Rail TW, et al, eds. The Pharmacological Basis of Therapeutics. New York. NY: Macmillan; 1985:446-472
20. Champman A, Keane PE, Meldrum BS, et al. Mechanism of anticonvulsant action of valproate. Prog Neurobiol 1982;19:315-359
21. McElroy SL, Keck PE Jr, Pope HG Jr. Sodium valproate: its use in primary psychiatric disorders J Clin Psychopharmacol 1987;7:16-24
22. Keck PE Jr, McElroy SL, Tugrul KC, et al. Valproate oral loading in the treatment of acute mania. J Clin Psychiatry 1993;54:305-308
23. Arana GW, Hyman SE. Handbook of Psychiatric Drug Therapy. 2nd ed. Boston, Mass: Little, Brown: 1991
24. SAS User's Guide: Statistics. 6th ed. Cary, NC: SAS Institute Inc; 1990
25. Post RM, Rubinow DR, Ballenger JC. Conditioning and sensitization in the longitudinal course of affective illness. Br J Psychiatry 1986; 149:191-201
26. Klein DF, Oaks G. Importance of psychiatric diagnosis in prediction of clinical drug effects. Arch Gen Psychiatry 1967;16:118-126
27. Chouinard G, Young SN, Annable L. Antimanic effect of clonazepam. Biol Psychiatry 1983;18:451-466
28. Hirschfeld RMA. American Psychiatric Association Practice Guidelines practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 1994;151(suppl):1-36
29. Gelenberg AJ, Kane JM, Keller MB, et al. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 1989;321:1489-1493